Crocs Inc. (NASDAQ:CROX) does about 1.76M shares in volume on a normal day but saw 1403521 shares change hands in Friday trading. The company now has a market cap of 7.50B USD. Its current market price is $122.40, marking an increase of 0.80% compared to the previous close of $121.43. The 52 week high reached by this stock is $131.18 whilst the lowest price level in 52 weeks is $46.08. The script in recent trading has seen the stock touch a high of $124.6296 and a low of $121.24.
Crocs Inc. (CROX) has a 20-day trading average at $113.85 and the current price is -6.69% off the 52-week high compared with 165.62% distance from its 52-week low. The 50-day simple moving average of the closing price is $102.60 and its 200-day simple moving average is $75.84. If we look at the stock’s price movements over the week, volatility stands at 3.42%, which increases to 4.52% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 65.61 to suggest the stock is neutral.
11 analysts observing the Crocs Inc. (CROX) stock have set the 12-month price targets for the company’s shares at between $103.00 and $165.00. The consensus objective for the share price is $133.00, suggesting that the stock has a potential upside of 7.97% over the period. The median price target is 5.85% away from the current levels at $130.00.
FactSet Research has provided data showing that 11 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 1 advise that it is a overweight. 6 analysts have rated it as a buy and 4 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.
Loop Capital upgraded its price target at $75.
The current price level is 8.84%, 20.28%, and 61.90% away from its SMA20, SMA50, and SMA200 respectively, with the CROX price moving above the 50-day SMA on January 20. Crocs Inc. (CROX) stock is down -3.71% over the week and 30.42% over the past month. Its price is 12.88% year-to-date and 7.82% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2022, with the company’s earnings per share (EPS) of $3.24 above consensus estimates by $0.58. The company’s next earnings report is expected on 05/04/2023, with forecasts estimating quarterly EPS at $2.61 and $10.08 for whole year. CROX’s earnings per share are forecast to grow by 21.20% this year and 4.00% over next year. Expected sales for next quarter are $892.5 million, which analysts say will come at $3.46 billion for the current fiscal year and next year at $3.84 billion. In addition, estimates put the company’s current quarterly revenue at an average of $942.21 million.
Its 12-month price target is $130.00. To reach the target analysts have set, the stock logically needs to grow 7.97 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $103.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $165.00.
Outstanding shares total 61.69M with insiders holding 2.83% of the shares and institutional holders owning 82.12% of the company’s common stock. The company has a return on investment of 94.80% and return on equity of 150.00%. The price to earnings ratio (P/E ratio) amounts to 13.50 while the forward price to earnings ratio is 11.26. The beta has a value of 1.92. Price to book ratio is 11.98 and price to sales ratio is 2.35.
According to a U.S. Securities and Exchange Commission filing, Fidelity Blue Chip Growth Fund has reduced its position in Crocs Inc. (CROX) to 2,329,024 shares, mirroring a recent drop by -12.90%. Fidelity Blue Chip Growth Fund dumped -0.35 million shares of Crocs Inc. common stock bringing its total worth to about $252.54 million at the end of recent close, SEC documents show. Fidelity Blue Chip Growth Fund isn’t the only investment manager who changed stakes and is followed by iShares Core S&P Mid Cap ETF, which sold off 363.0 shares to end up with 1,904,953 shares worth $206.55 million. Vanguard Total Stock Market Index raise their holdings by 1.10% in the company over the course of the most recent quarter. It now holds a 2.89% position in Crocs Inc. thanks to 1.78 million shares amounting to $193.54 million.